Assessing the prognostic value of C-reactive protein/albumin ratio and lactate/albumin ratio in critically ill patients

Author:

Shivaswamy Rajendra Prasad1,Inaganti Nithin Sai1,Varsha Tandure1,Ashok P1,Adarsh L. S1,Kiran H. S1,Chandra B. J Subhash1

Affiliation:

1. General Medicine, JSS Medical College, JSSAHER, Mysuru, Karnataka, India

Abstract

ABSTRACT Background: The ability to predict the fate of critically ill patients admitted to an intensive care unit is very important as there are only a few studies which have focused on this aspect. Our study focused to determine the relationship between C-reactive protein/albumin ratio (CAR) and lactate/albumin ratio (LAR) and intensive care unit stay, the requirement for vasopressor and mechanical ventilator support, and recovery and mortality in the patients admitted to critical care units. Methods: The study group comprised 100 patients who were admitted to critical care units. These patients were evaluated using a structured proforma, detailed case history, and clinical examination. Blood sample collection was done immediately after admission, and serum albumin, lactate, and C-reactive protein levels were estimated in these patients. Results: The mean age of the patients was 54.05. 74% of the patients were males. The common diagnosis was COVID bronchopneumonia. The patients with high LAR and high CAR values had either increased risk of mortality or increased duration of stay in the hospital (P = 0.0001). Patients with a low albumin level and high CRP required ventilator support, which was statistically significant. Patients who needed inotropic support and mechanical ventilator support had higher CAR (P = 0.001). Patients who received inotrope support had higher ESR and CRP levels. Conclusions: CAR and LAR are better indicators of mortality and duration of stay. CAR was found to be a better indicator of mortality than LAR, and it was also noted that the patients who required inotropes and mechanical ventilator support were found to have a higher CAR.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3